From the first launch to ongoing market access operational execution, IntegriChain solves some of the most complex and pressing challenges associated with drug commercialization. We deliver pharma’s only comprehensive data, consulting, and business process platform for market access departments, providing the strategy, data, applications, and infrastructure for therapy commercialization.
Solutions overview
IntegriChain delivers the pharmaceutical industry’s largest and only data and business process platform for therapy commercialization and access. Manufacturers rely on our analytics, applications, and managed services to power their operations and harness the value of their channel, patient and payer data.
View all products
IntegriChain provides a complete set of professional services for commercialization and market access execution–from life science strategy and operational consulting to implementation, integration, migrations, and analytics.
Services overview
We help all stakeholders in the pharmaceutical industry drive access with our relentless focus on unifying all of the critical business functions for therapy commercialization and access – contracts & pricing, gross-to-net, channel, and patient services – to unlock strategic payer, provider, pharmacy and patient access insights.
Learn more about our company
Learn more about joining our growing IntegriChain team of data scientists, market access experts, analysts, and consulting professionals – our culture, our purpose, our teams in the US and Pune. Check out our careers or keep in touch for future opportunities.
Careers overview
September 15, 2021 | OnDemand
As the GTN bubble grows, so does increased stakeholder scrutiny on GTN analytics. Although the industry is moving toward automating GTN processes, many life sciences manufacturers are not embracing automation at pace with the industry and often face obstacles in achieving their automation goals.
In this informative webinar, Jen Sharpe, GTN lead and facilitator of the Revenue Analytics Collaborative at IntegriChain reviews the results of the recent GTN Automation survey and report, discusses the value of automation, and the best ways to build a business case within the organization. Topics covered include:
Jen Sharpe
